Symmetry Partners’s Colgate-Palmolive CL Stock Holding History

Symmetry Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,315	Closed	-$516K	–	169
2024 Q2	$516K	Sell	5,315 -464	-8%	-$42.8K	0.03%	275
2024 Q1	$520K	Hold	5,779	–	–	0.04%	295
2023 Q4	$458K	Sell	5,779 -183	-3%	-$13.8K	0.02%	302
2023 Q3	$424K	Sell	5,962 -1,739	-23%	-$130K	0.02%	351
2023 Q2	$593K	Hold	7,701	–	–	0.03%	290
2023 Q1	$579K	Hold	7,701	–	–	0.03%	288
2022 Q4	$607K	Hold	7,701	–	–	0.04%	280
2022 Q3	$541K	Hold	7,701	–	–	0.04%	285
2022 Q2	$617K	Hold	7,701	–	–	0.04%	261
2022 Q1	$584K	Hold	7,701	–	–	0.04%	326
2021 Q4	$657K	Hold	7,701	–	–	0.04%	315
2021 Q3	$573K	Hold	7,701	–	–	0.04%	358
2021 Q2	$626K	Hold	7,701	–	–	0.04%	349
2021 Q1	$607K	Sell	7,701 -656	-8%	-$51.4K	0.04%	333
2020 Q4	$715K	Sell	8,357 -739	-8%	-$61.1K	0.06%	263
2020 Q3	$702K	Buy	+9,096	New	+$694K	0.06%	228

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Symmetry Partners's CL Position: Q3 2024 in Review

Symmetry Partners sold out of Colgate-Palmolive (CL) in Q3 2024, closing a stake of 5,315 shares — an estimated $516K sold.

Symmetry Partners first reported a position in CL in Q3 2020 and held it in 16 quarters. The position peaked at $715K in Q4 2020. 1,909 funds tracked by Wall St. Rank hold CL as of Q3 2024.

Symmetry Partners reported no remaining Colgate-Palmolive position as of Q3 2024 after selling out during the quarter.
Symmetry Partners sold 5,315 Colgate-Palmolive shares in Q3 2024, an estimated $516K.
Symmetry Partners first reported a position in Colgate-Palmolive in Q3 2020 and held it in 16 quarters.
Symmetry Partners's Colgate-Palmolive position peaked at $715K in Q4 2020.
1,909 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.

Based on Symmetry Partners's 13F filing for Q3 2024, filed 29 Oct 2024.